|
Volumn 67, Issue 3, 2014, Pages 403-406
|
Electrochemotherapy for the treatment of ocular basal cell carcinoma; A novel adjunct in the disease management
|
Author keywords
Basal cell carcinoma; Co morbidity; Electrochemotherapy; Ocular
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
ABSENCE OF SIDE EFFECTS;
AGED;
ARTICLE;
BASAL CELL CARCINOMA;
CANCER PATIENT;
CANCER SURGERY;
CASE REPORT;
COMORBIDITY;
DRUG EFFICACY;
DRUG SAFETY;
ELECTROCHEMOTHERAPY;
ELECTROPORATION;
EYE;
EYE BIOPSY;
EYE CANCER;
EYE SURGERY;
GENERATOR;
HUMAN;
LOWER EYELID;
NEEDLE ELECTRODE;
OCULAR BASAL CELL CARCINOMA;
PRIORITY JOURNAL;
TREATMENT RESPONSE;
TUMOR LOCALIZATION;
TUMOR VOLUME;
UPPER EYELID;
VERY ELDERLY;
WOUND DRESSING;
BASAL CELL CARCINOMA;
CO-MORBIDITY;
ELECTROCHEMOTHERAPY;
OCULAR;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS;
BLEOMYCIN;
CARCINOMA, BASAL CELL;
ELECTROCHEMOTHERAPY;
EYELID NEOPLASMS;
FEMALE;
HUMANS;
INJECTIONS, INTRALESIONAL;
SKIN NEOPLASMS;
|
EID: 84896712965
PISSN: 17486815
EISSN: 18780539
Source Type: Journal
DOI: 10.1016/j.bjps.2013.07.019 Document Type: Article |
Times cited : (36)
|
References (10)
|